1-15 of 15
Valentín García Gutiérrez, PhD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Efficacy and Safety of Bosutinib By Charlson Comorbidity Index in Previously Treated Patients with Chronic Myeloid Leukemia: Results from the Phase 4 BYOND Study

Carlo Gambacorti-Passerini, MD, Tim H Brümmendorf, MD, Bjorn T. Gjertsen, MD PhD, Camille Abboud, MD, Gianantonio Rosti, MD, Elisabetta Abruzzese, MD, Eric Leip, PhD, Andrea Viqueira, MD, Valentín García Gutiérrez, PhD, Frank Giles, MD, Andreas Hochhaus, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 2936.
https://doi.org/10.1182/blood-2019-121813
Published: 2019
Journal Articles

Different Clinical Implications of Kinase Domain BCR-ABL1 Variants Detected in Chronic Myeloid Leukemia and Acute Lymphoblastic Leukemia Patients

Ricardo Sanchez, PhD MD, Rosa Ayala, MD PhD, Gonzalo Carreño Gomez-Tarragona, Espino Maria Jose, Beatriz Cuevas, MD, Vanegas Raul, Luis Felipe Casado Montero, MD, Nuria Garcia-Ormeña, jose Angel Hernandez, Pilar Bravo, Cristina Seri, Eduardo Anguita, Eva Barragán, Francisca Ferrer Marin, MD PhD, maria Dolores Monteagudo, sanchez-Calero Jorge, Julian Sevilla, MD PhD, Elena Ruiz, Lucia Villalon, PhD, maria Del Mar Herraez, Rosalia Riaza, Elena Magro, Juan Luis Steegmann, Valentín García Gutiérrez, PhD, Joaquin Martinez-Lopez, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 5368.
https://doi.org/10.1182/blood-2019-127069
Published: 2019
Journal Articles

Validation of Daraex to Resolve Daratumumab-Induced Interferences in Pre-Transfusion Screen Tests

Maria Tenorio, PhD, Gemma Moreno Jiménez, MD, Valentín García Gutiérrez, PhD, Ana Jiménez, Maria Jesús Blanchard, MD, Ana Vallés, Sandra López, Pilar Herrera, MD, Javier Lopez Jimenez, MD PhD, Anabelle Chinea, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 4983.
https://doi.org/10.1182/blood-2019-131345
Published: 2019
Journal Articles

Survival Analysis According to Minimal Residual Disease By Flow Cytometry in Acute Myeloid Leukemia after First Induction

Claudia Nunez-Torron, MD, Juan Marquet Palomanes, MD, Fernando Martín Moro, Adolfo Saez-Martin, MD, Alejandro Luna, MD, Irene Garcia-Garcia, Berta Mercedes Michael Fernández, Jesus Villarrubia, PhD, Miguel Piris-Villaespesa, MD, Ernesto Roldan Santiago, Eulalia Rodríguez Martín, Gemma Moreno, MD, Valentín García Gutiérrez, PhD, Javier Lopez Jimenez, MD PhD, Pilar Herrera Puente
Journal: Blood
Blood (2019) 134 (Supplement_1): 1433.
https://doi.org/10.1182/blood-2019-130190
Published: 2019
Journal Articles

Feasibility of Treatment Discontinuation in Chronic Myeloid Leukemia in Clinical Practice in Spain: Results from a Nationwide Series of 236 Patients

Juan Carlos Hernandez Boluda, MD PhD, Arturo Pereira, MD PhD, Irene Pastor-Galán, MDcal Doctor, Alberto Alvarez-Larrán, MD PhD, Alisa Savchuk, Jose Manuel Puerta, Jose M. Sanchez, Rosa Collado, Álvaro Díaz, Anna Angona, MD PhD, Miguel Sagüés, Valentín García Gutiérrez, PhD, Concepcion Boque, MD PhD, Ignacio Gómez-Centurión, MD, Rolando Vallansot, MD, Luis Palomera, MD PhD, Arantxa Mendizábal, Luis Felipe Casado, MD, Manuel Pérez-Encinas, Raul Perez Lopez, Francisca Ferrer Marin, MD PhD, Fermin Sanchez-Guijo, MD PhD, Carmen Garcia-Hernandez, MD, Natalia de las Heras, Jose Luiz Lopez Lorenzo, MD, Francisco Cervantes, MD PhD, Juan Luis Steegmann, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 47.
https://doi.org/10.1182/blood-2018-99-109976
Published: 2018
Journal Articles

Prevalence of JAK2 V617F in Individuals That Meet World Health Organization Erythrocytosis Criteria for Polycythemia Vera

Miguel Piris-Villaespesa, Gloria Muñoz-Martin, PhD, Ricardo Sanchez, Claudia Nuñez-Torron, MD, Adolfo Saez-Martin, MD, Borja Fernandez-Felix, Javier Zamora, Francisco Javier del Castillo, Jose Manuel del Rey, Javier Lopez Jimenez, MD PhD, Jesus Villarrubia, PhD, Joaquin Martinez Lopez, MD PhD, Valentín García Gutiérrez, PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 1775.
https://doi.org/10.1182/blood-2018-99-110619
Published: 2018
Journal Articles

Bosutinib or Imatinib in Older Vs Younger Patients with Newly Diagnosed Chronic Myeloid Leukemia in the Phase 3 BFORE Trial

Michael W. Deininger, MD PhD, Vamsi Kota, MBBS, Jeff H. Lipton, MD PhD, Dragana Milojkovic, MBBS, PhD, Valentín García Gutiérrez, PhD, Eric Leip, PhD, Sonja Nick, MSc, Andreas Hochhaus, MD, Carlo Gambacorti-Passerini, MD, Jorge E. Cortes, MD, Tim H. Brummendorf, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 1734.
https://doi.org/10.1182/blood-2018-99-110798
Published: 2018
Journal Articles

Ruxolitinib in Refractory Acute and Chronic Graft-Versus-Host Disease: A Multi-Center Survey Study

Virginia Escamilla Gomez, Valentín García Gutiérrez, PhD, Teresa Caballero-Velázquez, MD PhD, Nancy Rodríguez-Torres, MD, Ildefonso Espigado, MD PhD, Lucia Lopez Corral, Dolores Caballero, MD PhD, Irene García-Cadenas, Rodrigo Martino, MD PhD, Silvanna Daniela Saavedra Gerosa, Ariadna Pérez Martínez, Pedro Antonio González Sierra, Physician, Maria De La Cruz Viguria Alegria, Teresa Zudaire, Ingrid Magnolia Parra Salinas, Physician, Marc Poch, Physician, Marta González Vincent, Physician, Miguel Ángel Díaz Pérez, Physician, Blanca Molina Angulo, Isabel Sanchez-Ortega, Physician, Rocio Parody Porras, Christelle M Ferra Coll, Guillermo Orti, David Valcarcel, MD, Rafael De La Camara, MD, Paula Molés, Physician, Jaime Sanz, Juan Montoro Gómez, Kyra Velázquez-Kennedy, José A. Pérez-Simón
Journal: Blood
Blood (2017) 130 (Supplement 1): 1983.
https://doi.org/10.1182/blood.V130.Suppl_1.1983.1983
Published: 2017
Journal Articles

Bosutinib Vs Imatinib for Newly Diagnosed Chronic Myeloid Leukemia (CML) in the BFORE Trial: 18 Month Follow-up

Carlo Gambacorti-Passerini, MD, Michael W. Deininger, MD PhD, Michael J. Mauro, MD, Charles Chuah, MD, Dong-Wook Kim, MD PhD, Iryna Dyagil, MDPhD, Natalia Glushko, Dragana Milojkovic, MBBS, PhD, Philipp D. le Coutre, MD, Valentín García Gutiérrez, PhD, Rocco J. Crescenzo, DO, FACOI, Eric Leip, PhD, Nathalie Bardy-Bouxin, PhD, Andrea Hochhaus, Prof. Dr., Timothy H. Brümmendorf, Jorge E. Cortes, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 896.
https://doi.org/10.1182/blood.V130.Suppl_1.896.896
Published: 2017
Journal Articles

Bosutinib Versus Imatinib for Newly Diagnosed Chronic Myeloid Leukemia: 12-Month Patient-Reported Outcomes from the BFORE Trial

Jorge E. Cortes, MD, Carlo Gambacorti-Passerini, MD, Michael W. Deininger, MD PhD, Michael J. Mauro, MD, Charles Chuah, MD, Dong-Wook Kim, MD PhD, Iryna Dyagil, MDPhD, Nataliia Glushko, Dragana Milojkovic, MBBS, PhD, Philipp D. le Coutre, MD, Valentín García Gutiérrez, PhD, Laurence Reilly, Allison Jeynes-Ellis, Rocco J. Crescenzo, DO, FACOI, Carla Mamolo, Arlene Reisman, Nathalie Bardy-Bouxin, PhD, Andrea Hochhaus, Prof. Dr., Timothy H. Brümmendorf
Journal: Blood
Blood (2017) 130 (Supplement 1): 2895.
https://doi.org/10.1182/blood.V130.Suppl_1.2895.2895
Published: 2017
Journal Articles

Dasatinib Discontinuation in Patients (Pts) with Chronic-Phase Chronic Myeloid Leukemia (CML-CP) and Stable Deep Molecular Response (DASFREE)

Neil P. Shah, MD PhD, Jose Valentín García Gutiérrez, PhD, Antonio Jiménez-Velasco, MD, Sarah M Larson, MD, Susanne Saussele, MD, Delphine Rea, MD, François-Xavier Mahon, MD PhD, Moshe Levy, MD, María Teresa Gómez-Casares, MD PhD, Fabrizio Pane, MD, Franck-Emmanuel Nicolini, MD PhD, Michael J. Mauro, MD, Oumar Sy, PhD, Patricia Martin-Regueira, MD, Jeffrey H. Lipton, PhD MD FRCPC
Journal: Blood
Blood (2017) 130 (Supplement 1): 314.
https://doi.org/10.1182/blood.V130.Suppl_1.314.314
Published: 2017
Journal Articles

Bosutinib Vs Imatinib for Newly Diagnosed Chronic Myeloid Leukemia in the BFORE Trial: Results By 3-Month BCR-ABL1 Transcript Level

Andreas Hochhaus, Prof. Dr., Carlo Gambacorti-Passerini, MD, Michael W. Deininger, MD PhD, Michael J. Mauro, MD, Charles Chuah, MD, Dong-Wook Kim, MD PhD, Iryna Dyagil, MDPhD, Nataliia Glushko, Dragana Milojkovic, MBBS, PhD, Philipp D. le Coutre, MD, Valentín García Gutiérrez, PhD, Laurence Reilly, Allison Jeynes-Ellis, Rocco J. Crescenzo, DO, FACOI, Eric Leip, PhD, Nathalie Bardy-Bouxin, PhD, Timothy H. Brümmendorf, Jorge E. Cortes, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 1618.
https://doi.org/10.1182/blood.V130.Suppl_1.1618.1618
Published: 2017
Journal Articles

Bosutinib in Newly Diagnosed Chronic Myeloid Leukemia (CML): Gastrointestinal (GI), Liver, and Hematological Safety Characterization in the BFORE Trial

Michael J. Mauro, MD, Carlo Gambacorti-Passerini, MD, Michael W. Deininger, MD PhD, Charles Chuah, MD, Dong-Wook Kim, MD PhD, Iryna Dyagil, MDPhD, Natalia Glushko, Dragana Milojkovic, MBBS, PhD, Philipp D. le Coutre, MD, Valentín García Gutiérrez, PhD, Laurence Reilly, Allison Jeynes-Ellis, Rocco J. Crescenzo, DO, FACOI, Roberto Uehara, Eric Leip, PhD, Liza DeAnnuntis, Nathalie Bardy-Bouxin, PhD, Andreas Hochhaus, MD, Timothy H. Brümmendorf, Jorge E. Cortes, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 1620.
https://doi.org/10.1182/blood.V130.Suppl_1.1620.1620
Published: 2017
Journal Articles

A Conservative Tailoring of Ponatinib Dose in Chronic Myeloid Leukemia Patients Can Diminish Adverse Events While Maintaining Efficacy

Valentín García Gutiérrez, PhD, Andrés Novo, MD, Antonio Jimenez-Velasco, Luis Felipe Casado Montero, MD, Fermin Sanchez-Guijo, MD PhD, Raul Perez Lopez, Santiago Osorio-Prendes, Sunil Lakhwani Lakhwani, Angel Ramirez Payer, Guillermo Orti, Maria Teresa Gomez-Casares, Juan Manuel Alonso, Manuel Pérez-Encinas, Rolando Vallansot, Ernesto Pérez Persona, Maria Angeles Portero Frias, María José Ramírez Sánchez, Maria Alicia Senin, Gonzalo Caballero, Soledad Noya, Concepcion Boque, Maribel Mata, Mario Romo, Juan Luis Steegmann, MD PhD, Juan Carlos Hernandez-Boluda, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 1624.
https://doi.org/10.1182/blood.V130.Suppl_1.1624.1624
Published: 2017
Journal Articles

Clinical Impact Of The Simultaneous Detection Of Anti-Erythocytic Autoantibodies In Alloimmunization

Maria C Tenorio Nuñez, PhD, Gemma Moreno Jimenez, MD, Manuel Hernandez Jodra, PhD, Lorena Abalo, MD, Juan Manuel Alonso, MD, Javier Garcia Lledo, MD, Jose Valentin Garcia Gutierrez, PhD, Carlos Montalban, PhD, Concepcion Zamora De Pedro, PhD, Francisco Javier Lopez Jimenez, PhD
Journal: Blood
Blood (2013) 122 (21): 4828.
https://doi.org/10.1182/blood.V122.21.4828.4828
Published: 2013